Roche Holding AG (XSWX:ROG)
CHF 251 0 (0%) Market Cap: 201.45 Bil Enterprise Value: 231.01 Bil PE Ratio: 18.96 PB Ratio: 6.91 GF Score: 93/100

Roche Holding AG Virtual Early Drug Development pRED Event Call Transcript

Nov 11, 2019 / 01:00PM GMT
Release Date Price: CHF297.95 (+0.18%)
Operator

Ladies and gentlemen, welcome to the Roche Virtual Early Drug Development pRED Event 2019 Conference Call. I am Sharry, the Chorus Call operator. (Operator Instructions) The conference must not be recorded for publication or broadcast.

At this time, it's my pleasure to hand over to Mr. Karl Mahler, Head of Investor Relations. Please go ahead, sir.

Karl Mahler
Roche Holding AG - Head of IR

Yes. So good morning, and good afternoon, ladies and gentlemen. This is actually the first of 2 events we will do for the early stage setup, so our research engine, I would like to say. So we will have this -- today's focused on pRED, but we will have another one also in early next year, focusing on the Genentech early research and development.

Today, I'm joined by William Pao, the Head of the pRED Research Engine. He will give us an overview and introduction on the setup. We have Christian Rommel with us, the Global Head of pRED Oncology. Neuroscience will be represented by Azad Bonni, Global Head of pRED and Rare Diseases. Ophthalmology, Sascha Fauser,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot